U.S. Stem Cell, Inc.
$0.00▲ 0.00%(+$0.00)
TickerSpark Score
47/100
▌ Weak
60
Valuation
60
Profitability
55
Growth
28
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a USRM research report →
52-Week Range50% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.us-stemcell.com
About the company
U. S. Stem Cell, Inc.
- CEO
- Michael Tomas
- IPO
- 2008
- Employees
- 11
- HQ
- Sunrise, FL, US
Price Chart
-0.00% · this period
Valuation
- Market Cap
- $64.15K
- P/E
- -0.02
- P/S
- 0.78
- P/B
- -0.00
- EV/EBITDA
- -4.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 71.03%
- Op Margin
- -2096.90%
- Net Margin
- -3483.21%
- ROE
- 20.78%
- ROIC
- 29.95%
Growth & Income
- Revenue
- $82.05K · -59.13%
- Net Income
- $-2,857,943 · 13.06%
- EPS
- $-0.00 · 32.39%
- Op Income
- $-1,720,484
- FCF YoY
- 71.18%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -48.37
- Avg Volume
- 16.97K
Get TickerSpark's AI analysis on USRM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 25, 22 | Knutson Gregory | other | 2,500,000 |
| Mar 18, 22 | Knutson Gregory | other | 25,000,000 |
| Feb 24, 22 | Knutson Gregory | other | 12,500,000 |
| Feb 24, 22 | Knutson Gregory | other | 12,500,000 |
| Mar 23, 21 | MURPHY WILLIAM P JR | other | 7,518,797 |
| Apr 2, 21 | Knutson Gregory | other | 187,575 |
| Oct 5, 20 | Knutson Gregory | other | 2,035,820 |
| Apr 1, 20 | Knutson Gregory | other | 1,445,647 |
| Feb 17, 21 | Knutson Gregory | other | 3,759,398 |
| Nov 18, 19 | TOMAS MIKE | other | 1,500,000 |
Coverage · USRM
Our USRM coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on USRM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate USRM report →Internal Compare
Similar companies
Peers in the same neighborhood.
DNAG▲0.00%
DNAPrint Genomics, Inc.
$0.00
IPAH▲0.00%
Interpharm Holdings, Inc.
$0.00
AVXT▲0.00%
AVAX Technologies, Inc.
$0.00
LADX▼89.72%
LadRx Corporation
$0.01
MOBO▲0.00%
Mobile Lads Corp.
$0.00
REFG▲0.00%
Medical Cannabis Payment Solutions
$0.00
BRAXF▲0.00%
Braxia Scientific Corp.
$0.00
MHTX▲0.00%
Manhattan Scientifics, Inc.
$0.00